|
Industry Focus: Privately held companies with a focus in the pharmaceutical, biotechnology, medical device and diagnostics dustries.
Select Healthcare Services companies with a technology concentration or in a highly specialized market niche are also considered.
|
 |
Stage: Companies looking for early and growth stage investment with proof of concept
completed and revenues at or rapidly approaching a breakeven level of cash flow.
Investment Size: Typically a total of between $100,000 and $2,000,000 of fund capital. We
have co-investors who also consider additional investment in projects on a case-by-case basis.
Holding Period: Average anticipated holding periods of 2-4 years with a clearly identifiable exit strategy.
Board Representation: Although we hold board seats with the majority of our portfolio companies, a
board seat is not a strict requirement of the fund.
Primary Areas of Evaluation
- A proprietary technology or product that originates from an academic research institution in Alabama
- Patent or patent pending technology
- An experienced management team with strong technical and strategic leadership
- Industry transforming business models
- Existing or emerging revenue platforms
- Potential to gain a significant share of a large or rapidly growing market
